Literature DB >> 8343231

Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.

S E Campbell1, J S Janicki, B B Matsubara, K T Weber.   

Abstract

In both humans and experimental animals, mineralocorticoid (MC)-induced hypertension is associated with myocardial fibrosis. We have shown that this fibrous tissue response includes a reactive interstitial fibrosis not initiated by parenchymal cell loss, and a reparative fibrosis or scarring, occurring in response to cardiac myocyte necrosis. The reactive fibrosis is thought to be related to MC excess, while cell loss and microscopic scarring may be secondary to enhanced potassium excretion or a cytotoxic effect of aldosterone. This histologic study was undertaken to determine whether or not the potassium sparing diuretic amiloride would be effective in preventing the appearance of either form of fibrosis. Uninephrectomized male Sprague Dawley rats received either aldosterone (AL; 0.75 microgram/h), amiloride (AMC; 1 mg/kg/day), aldosterone+amiloride (ALAM), or vehicle (ALC) alone via subcutaneous osmotic minipumps for 8 weeks. All rats received 1% NaCl in their drinking water. Hearts were recovered, immersion-fixed, and tissue sections from both left and right ventricles stained with the collagen specific stain Sirius Red F3BA were morphometrically analyzed. The interstitial collagen volume fraction was elevated in AL and ALAM groups compared to ALC and AMC, but did not differ between AL and ALAM. Microscopic scarring, found in both ventricles, was evident in AL animals, but was not found in the ALAM, AMC, or ALC groups. These data suggest that chronic elevations in plasma aldosterone, relative to dietary sodium intake, do not have a direct cytotoxic effect on cardiac myocytes, but they are associated with a reactive interstitial fibrosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343231     DOI: 10.1093/ajh/6.6.487

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

Review 1.  Vascular remodeling and mineralocorticoids.

Authors:  K T Weber; Y Sun; S E Campbell; S H Slight; V K Ganjam
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Authors:  Wenxia Chai; Ingrid M Garrelds; Udayasankar Arulmani; Regien G Schoemaker; Jos M J Lamers; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.

Authors:  Stevo Mirkovic; Anne-Marie L Seymour; Andrew Fenning; Anna Strachan; Solomon B Margolin; Stephen M Taylor; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.

Authors:  Lu Liang; Xin Wang; Yang Yu; Yuan Zhang; Jiamei Liu; Mulei Chen; Lin Zhang; Tao Jiang
Journal:  Int J Gen Med       Date:  2022-04-18

5.  Aldosterone induces mesangial cell apoptosis both in vivo and in vitro.

Authors:  Jayant T Mathew; Hitesh Patni; Ahmad N Chaudhary; Wei Liang; Aakriti Gupta; Praveen N Chander; Guohua Ding; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-07

6.  Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.

Authors:  German Kamalov; Prajwal A Deshmukh; Narina Y Baburyan; Malay S Gandhi; Patti L Johnson; Robert A Ahokas; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2009-05       Impact factor: 3.105

7.  Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death.

Authors:  Patricia R Hebert; Christopher S Coffey; Daniel W Byrne; Theresa A Scott; Robert H Fagard; Jeffrey N Rottman; Katherine T Murray; John A Oates
Journal:  J Am Soc Hypertens       Date:  2008 Sep-Oct

8.  Elucidation of Anti-Hypertensive Mechanism by a Novel Lactobacillus rhamnosus AC1 Fermented Soymilk in the Deoxycorticosterone Acetate-Salt Hypertensive Rats.

Authors:  Haicui Wu; Lilong Jiang; Tim-Fat Shum; Jiachi Chiou
Journal:  Nutrients       Date:  2022-08-02       Impact factor: 6.706

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.